Treatment of multicentric reticulohistiocytosis with adalimumab, minocycline, methotrexate

被引：12
|
作者：
Yeter, Karen C. [1 ]
Arkfeld, Daniel G. [1 ]
机构：
[1] Univ So Calif, Keck Sch Med, Dept Med Rheumatol, Los Angeles, CA 90033 USA
来源：
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES | 2013年 / 16卷 / 01期
关键词：
ARTHRITIS;
D O I：
10.1111/j.1756-185X.2012.01762.x
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：105 / 106
页数：2
相关论文
共 50 条
  • [31] Efficacy and safety evaluations of adalimumab biosimilars in the treatment of psoriasis
    Li, Changkun
    Sunhe, Yixuan
    Zhou, Hui
    Dong, Weihua
    JOURNAL OF DERMATOLOGICAL TREATMENT, 2023, 34 (01)
  • [32] Clinical Experience with Adalimumab in the Treatment of Ocular Behcet Disease
    Bawazeer, Ahmed
    Raffa, Lina H.
    Nizamuddin
    OCULAR IMMUNOLOGY AND INFLAMMATION, 2010, 18 (03) : 226 - 232
  • [33] Adalimumab treatment for severe recalcitrant chronic plaque psoriasis
    Ryan, C.
    Kirby, B.
    Collins, P.
    Rogers, S.
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2009, 34 (07) : 784 - 788
  • [34] Methotrexate in the treatment of peripheral arthritis in ulcerative colitis
    Peluso, R.
    Atteno, M.
    Iervolino, S.
    Bruner, V.
    Caso, F.
    Costa, L.
    Raimondo, M.
    Lofrano, M.
    Manguso, F.
    Scarpa, R.
    REUMATISMO, 2009, 61 (01) : 15 - 20
  • [35] Non-Langerhans cell histiocytosis with peripheral joint destruction and mediastinal lymph node invasion: The continuous feature spectrum of clinical multicentric reticulohistiocytosis and microscopical xanthoma disseminatum
    Yu, Yi-Hsiang
    Lee, Chih-Hung
    Lin, Shang-Hung
    DERMATOLOGICA SINICA, 2020, 38 (03) : 176 - 179
  • [36] Combination of sulphasalazine and methotrexate in the treatment of rheumatoid arthritis
    M. Dougados
    Zeitschrift für Rheumatologie, 1998, 57 : 31 - 33
  • [37] Guillain-Barre syndrome in a patient on adalimumab for the treatment of psoriasis
    de Natividade, Natallia Barreiros
    Oldani Felix, Paulo Antonio
    Lerer, Claudio
    ANAIS BRASILEIROS DE DERMATOLOGIA, 2017, 92 (05) : 85 - 87
  • [38] Filgotinib versus placebo or adalimumab in patients with rheumatoid arthritis and inadequate response to methotrexate: a phase III randomised clinical trial
    Combe, Bernard
    Kivitz, Alan
    Tanaka, Yoshiya
    van der Heijde, Desiree
    Simon, J. Abraham
    Baraf, Herbert S. B.
    Kumar, Uma
    Matzkies, Franziska
    Bartok, Beatrix
    Ye, Lei
    Guo, Ying
    Tasset, Chantal
    Sundy, John S.
    Jahreis, Angelika
    Genovese, Mark C.
    Mozaffarian, Neelufar
    Landewe, Robert B. M.
    Bae, Sang-Cheol
    Keystone, Edward C.
    Nash, Peter
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (07) : 848 - 858
  • [39] Comparison of the efficacy and safety of LBAL, a candidate adalimumab biosimilar, and adalimumab reference product in patients with active rheumatoid arthritis inadequately responding to methotrexate: A 52-week phase III randomised study
    Matsuno, H.
    Kang, Y. M.
    Okada, M.
    Lee, S-, I
    Park, S-H
    Sheen, D. H.
    Sato, M.
    Hagino, A.
    Lee, J.
    Shin, S.
    Song, Y. W.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2022, 40 (05) : 1025 - 1033
  • [40] Patient safety in the treatment of rheumatic diseases Laboratory monitoring in methotrexate treatment
    Sierocinski, Elizabeth
    Angelow, Aniela
    Mainz, Armin
    Walker, Jochen
    Chenot, Jean-Francois
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2021, 80 (05): : 418 - 424
12345